Tethys Research
Mr. Steve Dubin is the Former CEO of Martek Biosciences Corporation (NASDAQ: MATK). Mr. Dubin played a key role in developing Martek’s business from an R&D company to a fully integrated, profitable, commercial organization with over $470M in annual sales. In December of 20120, Martek was acquired by Royal DSM N.V. for $1.1 billion. Mr. Dubin is a Principal at SDA Ventures LLC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Tethys Research
Tethys Research develops technology and utilizing it under contract with other organizations that produce and market chemical products.